-
Neurotensin: From NTR1 Mechanism to Translation
2026-10-01
Neurotensin can serve as a mechanistically informative probe of NTR1 signaling, receptor recycling, and miR-133α biology in intestinal models. This thought-leadership guide shows how to convert peptide stimulation into a translational workflow while separating established evidence, assay recommendations, and cross-domain analytical lessons.
-
Zika Phosphoproteome Maps Host Control of Virus Release
2026-10-01
A 2026 PLOS Pathogens study used mass spectrometry and functional analysis to map 43 host-driven post-translational modifications across eight Zika virus proteins. The work identifies envelope-protein phosphosites and host kinases that regulate viral particle release, cytopathogenicity, and viral growth, providing a framework for connecting phosphoproteomic discovery with phenotype.
-
Reparixin and the IL-8–CXCR1 Translational Axis
2026-09-30
A mechanistic and translational perspective on using Reparixin, a CXCR1/2 inhibitor, to test how IL-8 signaling links bacterial extracellular vesicles, oral cancer biology, neutrophil recruitment, and inflammatory injury.
-
FAST Nanoparticles for Food-Grade Nutraceutical Delivery
2026-09-30
The reference study evaluates Facilitated Self-Assembling Technology (FAST) as a surfactant-free, food-grade route for producing stable nanoparticles from poorly soluble nutraceuticals. Its findings indicate that FAST can improve colloidal behavior, simulated gastric stability, and formulation practicality while retaining favorable biocompatibility, although in vivo absorption and clinical performance remain to be established.
-
ALC-0159 in mRNA-LNP Immunotherapy Research
2026-09-29
ALC-0159 is a PEG-conjugated lipid excipient relevant to mRNA delivery and lipid nanoparticle design. This article explains how its formulation role can be evaluated alongside emerging evidence that mRNA vaccination may sensitize tumors to immune checkpoint inhibition.
-
D-Mannitol B2090: Practical Research Workflow Guide
2026-09-29
D-Mannitol (SKU B2090) is a water-soluble biochemical reagent for establishing controlled osmotic conditions in renal function studies, osmotic regulation research, and related diuretic mechanism investigation. It is intended for defined laboratory workflows rather than clinical use, and freshly prepared solutions should be used promptly because long-term solution storage is not recommended.
-
ER-Fusogenic Liposomes for Antitumor Vaccines
2026-09-28
The study describes phosphatidylinositol-based immunomodulatory nanoliposomes that pair dendritic-cell activation with endoplasmic-reticulum-directed antigen delivery. In mouse tumor models, OVA-loaded particles enhanced CD8 T-cell responses and tumor outcomes relative to MF59-adjuvanted OVA, supporting further study of self-adjuvanting vaccine designs while leaving important questions about translation and formulation unresolved.
-
Ciprofloxacin Hydrochloride for Single-Cell Assays
2026-09-27
Use Ciprofloxacin hydrochloride to probe bacterial DNA damage, antibiotic interactions, and cell-to-cell variation—not just bulk growth inhibition. A microfluidic workflow informed by recent single-cell research helps distinguish altered growth from increased survival when ciprofloxacin is paired with tetracycline.
-
Amphotericin B Workflows for Candida Biofilm Research
2026-09-26
Use Amphotericin B to compare planktonic susceptibility with biofilm response while keeping solvent, exposure, and viability measurements controlled. This workflow connects membrane-directed antifungal testing with recent evidence that PP2A-linked autophagy can shape Candida albicans biofilm drug resistance—without assuming the study established an Amphotericin B-specific effect.
-
Hyperthermia–Cisplatin Drives Caspase-8 Cell Death
2026-09-26
A 2024 study reports that combining hyperthermia with cisplatin promotes K63-linked polyubiquitination and accumulation of caspase-8, engaging both apoptotic and pyroptotic cell-death responses in cancer cells. The findings connect Cullin 3 and p62 to this response and highlight why caspase activity measurements should be interpreted alongside genetic and cell-death readouts.
-
CIH, Gut Co-Metabolomics, and Mitochondrial Apoptosis
2026-09-25
This study combines gut microbiome profiling, metabolomics, and lung apoptosis measurements to investigate how chronic intermittent hypoxia (CIH) is associated with mitochondrial injury. Its intervention results suggest that Mdivi-1 can lessen several CIH-related changes, while the data support—but do not prove—a causal gut microbiota–metabolite–mitochondria pathway.
-
Dual CDK4/6–BET Inhibition in Pancreatic Cancer
2026-09-25
Gu et al. report that combining CDK4/6 inhibition with BET inhibition suppresses pancreatic ductal adenocarcinoma growth while counteracting the pro-migratory, EMT-associated response observed with CDK4/6 inhibition alone. Their findings connect GSK3β-mediated Wnt/β-catenin activity with TGF-β/Smad signaling and support further testing of combination strategies in preclinical PDAC models.
-
Reparixin and CXCR1/2: From Inflammation to Tumors
2026-09-24
A mechanistic and translational framework for using Reparixin to investigate CXCR1/2 signaling—from neutrophil biology and tissue injury to emerging questions in MRSA-associated oral cancer—without confusing pathway validation with therapeutic proof.
-
Saquinavir: Mechanism, Permeability & Research Use
2026-09-24
Saquinavir is a potent HIV protease inhibitor used in antiretroviral research, and its product specifications support controlled in-vitro workflows. Biomimetic chromatography offers a way to study drug–membrane interactions, but the cited pulmonary-permeability study does not report a Saquinavir-specific result.
-
SOX7–DNMT3B/CYGB Axis in Bladder Cancer
2026-09-23
The reference study identifies SOX7 as a suppressor of bladder cancer progression and connects its activity to epigenetic control of CYGB through DNMT3B. Its combination of expression profiling, functional perturbation, promoter analysis, methylation assessment, and prognostic modeling provides a mechanistic framework for interpreting SOX7 and CYGB as linked biomarkers.